Background and Aim: Distal third tibia fractures accounts for about 7-9% of all lower extremity fractures. The treatment of distal tibia fractures is challenging, because of limited soft tissue coverage and poor vascularity. In the present study our aim is to assess the clinical and functional outcome of distal third tibia fractures treated by Minimally invasive percutaneous plate osteosynthesis. Materials and Methods: A total of 40 patients with distal tibia fracture was treated in this study from December 2018 to January 2020. TWS Scoring system was used to evaluated the functional outcome. Results: Majority of the study population (21, 52.5%) were belonging to the excellent outcome category, followed by good category among (14, 35.0%). Discussion: MIPPO technique offers biological advantage by preserving periosteal blood supply and it provides good stability to fracture site. Complication rate is less compared to other procedure.
Distal tibia fractures are one of commonest lower extremity fracture. The treatment is quite challenging, since it has poor vascularity and limited soft tissue coverings. There are various treatment modalities for the management of distal tibia fractures. Minimally Invasive techniques using locking compression plate has emerged as a popular treatment option because of its respect towards the biology of distal tibia, maintenance of fracture haematoma and providing a biomechanically stable fixation. It also has an advantage of early mobilization and minimal complications with a relatively higher rates on union. In this review article, we will evaluate the effectiveness of minimally invasive techniques for fractures involving distal Tibia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.